BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jha RM, Mondello S, Bramlett HM, Dixon CE, Shear DA, Dietrich WD, Wang KKW, Yang Z, Hayes RL, Poloyac SM, Empey PE, Lafrenaye AD, Yan HQ, Carlson SW, Povlishock JT, Gilsdorf JS, Kochanek PM. Glibenclamide Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy. J Neurotrauma 2021;38:628-45. [PMID: 33203303 DOI: 10.1089/neu.2020.7421] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Zusman BE, Wu Y, Kochanek PM, Vagni VE, Janesko-Feldman K, Gerzanich V, Simard JM, Karahalios K, Mihaljevic S, Raikwar S, Rani A, Rulney J, Desai SM, Catapano J, Jha RM. Precision Effects of Glibenclamide on MRI Endophenotypes in Clinically Relevant Murine Traumatic Brain Injury. Crit Care Med 2023;51:e45-59. [PMID: 36661464 DOI: 10.1097/CCM.0000000000005749] [Reference Citation Analysis]
2 Cummings J, Wu YL, Dixon CE, Henchir J, Simard JM, Panigrahy A, Kochanek PM, Jha RM, Aneja RK. Abcc8 (sulfonylurea receptor-1) knockout mice exhibit reduced axonal injury, cytotoxic edema and cognitive dysfunction vs. wild-type in a cecal ligation and puncture model of sepsis. J Neuroinflammation 2023;20:12. [PMID: 36681815 DOI: 10.1186/s12974-023-02692-2] [Reference Citation Analysis]
3 Chen X, Huang X, Liu C, Li S, Yang Z, Zhang F, Chen X, Shan H, Tao L, Zhang M. Surface-fill H(2)S-releasing silk fibroin hydrogel for brain repair through the repression of neuronal pyroptosis. Acta Biomater 2022;154:259-74. [PMID: 36402296 DOI: 10.1016/j.actbio.2022.11.021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ferdowsi S, Abdolmaleki A, Asadi A, Zahri S. Glibenclamide promoted functional recovery following sciatic nerve injury in male Wistar rats. Fundam Clin Pharmacol 2022. [PMID: 35524424 DOI: 10.1111/fcp.12796] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Whitener R, Henchir JJ, Miller TA, Levy E, Krysiewicz-Bell A, Abrams ESL, Carlson SW, Menon N, Dixon CE, Whalen MJ, Rogers CJ. Localization of Multi-Lamellar Vesicle Nanoparticles to Injured Brain Tissue in a Controlled Cortical Impact Injury Model of Traumatic Brain Injury in Rodents. Neurotrauma Rep 2022;3:158-67. [PMID: 35403102 DOI: 10.1089/neur.2021.0049] [Reference Citation Analysis]
6 Behar-cohen F, Loewenstein A. Current and Future Treatments for Diabetic Retinopathy. Pharmaceutics 2022;14:812. [DOI: 10.3390/pharmaceutics14040812] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Hu Y, Tao W. Microenvironmental Variations After Blood-Brain Barrier Breakdown in Traumatic Brain Injury. Front Mol Neurosci 2021;14:750810. [PMID: 34899180 DOI: 10.3389/fnmol.2021.750810] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Jha RM, Rani A, Desai SM, Raikwar S, Mihaljevic S, Munoz-Casabella A, Kochanek PM, Catapano J, Winkler E, Citerio G, Hemphill JC, Kimberly WT, Narayan R, Sahuquillo J, Sheth KN, Simard JM. Sulfonylurea Receptor 1 in Central Nervous System Injury: An Updated Review. Int J Mol Sci 2021;22:11899. [PMID: 34769328 DOI: 10.3390/ijms222111899] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
9 Jha RM, Raikwar SP, Mihaljevic S, Casabella AM, Catapano JS, Rani A, Desai S, Gerzanich V, Simard JM. Emerging therapeutic targets for cerebral edema. Expert Opin Ther Targets 2021;25:917-38. [PMID: 34844502 DOI: 10.1080/14728222.2021.2010045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Berdugo M, Delaunay K, Lebon C, Naud MC, Radet L, Zennaro L, Picard E, Daruich A, Beltrand J, Kermorvant-Duchemin E, Polak M, Crisanti P, Behar-Cohen FF. Long-Term Oral Treatment with Non-Hypoglycemic Dose of Glibenclamide Reduces Diabetic Retinopathy Damage in the Goto-KakizakiRat Model. Pharmaceutics 2021;13:1095. [PMID: 34371786 DOI: 10.3390/pharmaceutics13071095] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Tata S, Zusman BE, Kochanek PM, Gerzanich V, Kwon MS, Woo SK, Clark RSB, Janesko-Feldman K, Vagni VA, Simard JM, Jha RM. Abcc8 (Sulfonylurea Receptor-1) Impact on Brain Atrophy after Traumatic Brain Injury Varies by Sex. J Neurotrauma 2021. [PMID: 33940936 DOI: 10.1089/neu.2021.0105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Osier ND, Bramlett HM, Shear DA, Mondello S, Carlson SW, Dietrich WD, Deng-Bryant Y, Wang KKW, Hayes RL, Yang Z, Empey PE, Poloyac SM, Lafrenaye AD, Povlishock JT, Gilsdorf JS, Kochanek PM, Dixon CE. Kollidon VA64 Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy. J Neurotrauma 2021. [PMID: 33843262 DOI: 10.1089/neu.2021.0089] [Reference Citation Analysis]
13 李 娟. Application Prospect of Glibenclamide in Cerebral Hemorrhage Edema. ACM 2021;11:5492-5500. [DOI: 10.12677/acm.2021.1111813] [Reference Citation Analysis]